Trust in government agencies such as the Centers for Disease Control and Prevention has eroded in recent months, according to a poll from the nonpartisan Kaiser Family Foundation.
Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and former acting director of the CDC, told Cheddar the drop stems from the politicization of public health during the coronavirus pandemic.
"Repeatedly during this crisis, we've seen instances where the political sector has reached in and changed public health guidance from CDC," he said. "That is a real problem."
Indeed, House Democrats are currently investigating whether the Trump administration pressured CDC officials to alter or delay information on the coronavirus.
Besser said one challenge for the CDC is that it doesn't often speak with the public directly.
"There's incredibly important information coming out from the CDC every single day," he said. "Unfortunately the CDC is not in a position where they're talking to the public through the media every day to be able to lift up that information."
Once that information is politically influenced, he added, "then people have to pick and choose and say 'well is this a guidance that's science-based, or is this one that's politically based?'"
Bessner described trust as one of the CDC's most important tools because early on in a crisis the agency depends on people following the advice of experts despite considerable uncertainty.
As the U.S. continues to face supply chain shortages, President Joe Biden is reassuring U.S. consumers that the supply chain is in "very strong shape" ahead of the all-important holiday season. As supply bottlenecks start to show signs of improvement, the industry may be faced with yet another challenge: the Omicron variant. Rob Caucci, Co-Founder & Co-CEO of Fillogic joined Cheddar's Opening Bell to discuss.
Markets rebounded Monday morning after Friday's deep sell-off that saw the Dow suffer its worse day since 2020. It comes as investors continue to react to the impact of the omicron variant on the broader reopening. Eddie Ghabour, Co-Owner at the Key Advisors Group joined Cheddar's Opening Bell to discuss.
Markets bounced back this morning with travel leading the gains after plunging on Monday as the first case of Omicron was detected in the U.S. Jimmy Lee, CEO, Wealth Consulting Group joined Cheddar's Opening Bell to discuss.
The market saw investors react to comments by the World Health Organization's chief scientist, who suggested existing vaccines are likely to offer protection against the new variant. According to Thomas Hayes, chairman of Great Hill Capital, the next two weeks will be crucial as the markets watch for not only the effects of the Omicron variant, but also the Fed's decision on a taper.
It's Friday at long last. Jill and Carlo cover the latest on Omicron, including a possible superspreader event in NYC. Plus, previewing the November jobs report, a new Zoom feature no one asked for, and when it's no longer a good idea to eat Thanksgiving leftovers.
Following the Mississippi abortion case, the fate of Roe V. Wade is at stake. A decision is expected next summer, right around the time midterm candidates will be making their cases to voters. Laura Packard, executive director of Health Care Voter, joins Cheddar News to discuss how the ruling will impact upcoming elections.
Stock markets around the world continue to be impacted by fears of the new Omicron COVID-19 variant. President Biden today reiterated his stance that the new strain is cause for concern, but not cause for panic. Wells Fargo Investment Institute Global Equity Strategist Scott Wren joined Cheddar News' Closing Bell to discuss.
Jill and Carlo discuss what appears to be the beginning of the end of Roe v. Wade, another victim dies following the school shooting in Michigan, Omicron in the U.S., Trump's Covid chronology and more.
